ENaC蛋白表达上调引起内淋巴水钠代谢紊乱诱发膜迷路积水
批准号:
82101220
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
黄叔健
依托单位:
学科分类:
听觉异常与平衡障碍
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
黄叔健
中文摘要
膜迷路积水是梅尼埃病的重要病理学特征。既往研究表明,梅尼埃病患者血抗利尿激素(ADH)及醛固酮(ALD)水平均明显升高,但单纯应用利尿剂不能完全控制梅尼埃病眩晕发作。在泌尿系统中,ADH及ALD共同调节水钠平衡。上皮钠通道蛋白(ENaC)是ADH及ALD调节水钠平衡的关键靶点蛋白,但ENaC在膜迷路积水的形成过程中的作用尚不明确。本项目组前期研究发现ADH诱发膜迷路积水的豚鼠模型中,内淋巴囊上皮细胞的ENaC表达水平升高,表达水平与膜迷路积水严重程度正相关,因此我们提出假说:外源性ADH及ALD升高使ENaC表达上调引起钠离子转运失衡造成水钠潴留导致膜迷路积水。本项目通过基因敲除及应用ENaC拮抗剂调控ENaC表达的动物模型,观察给予外源性ADH和ALD干预前后听觉电生理、形态学及平衡功能的变化,探索ENaC在ALD和ADH造成膜迷路积水的作用及机制,为治疗梅尼埃病提供新的治疗靶点。
英文摘要
The pathology of Meniere's disease (MD) is well established to be endolymphatic hydrops. Previous studies have shown that the levels of antidiuretic hormone (ADH) and aldosterone (ALD) in peripheral blood of patients with Meniere's disease are significantly increased, but diuretics alone cannot control vertigo in MD. In the urinary system, ADH and ALD can jointly regulate the balance of water and sodium and Epithelial sodium channel (ENaC) is one of key target proteins for ADH and ALD to regulate water and sodium balance. However, the role of ENaC in the formation of endolymphatic hydrops is not clear. Our recent data showed that the expression of ENaC in endolymphatic sac epithelial cells increased in the guinea pig model of endolymphatic hydrops induced by ADH, and the expression level was positively correlated with the severity of endolymphatic hydrops, Based on these studies, we hypothesized that the increase of serum ALD and ADH leads to the up-regulation of ENaC expression, and consequently causing imbalance of sodium transport, water and sodium retention, leading to endolymphatic hydrops. Accordingly, the role of ENaC in the formation of endolymphatic hydrops using gene knock-in and knock-out were evaluated before and after exposure to ADH and ALD in adult mice, and the protective effects id ENaC antagonists against endolymphatic hydrops were explored. We sought to determine whether up-regulation of ENaC expression leads to endolymphatic hydrops and the pothetial mechanism. Together, this study strongly supports ENaC as a potential therapeutic target with the potential to inhibit endolymphatic hydrops in patients with MD.
膜迷路积水是梅尼埃病的重要病理学特征。本项目组前期研究发现抗利尿激素(ADH)诱发膜迷路积水的豚鼠模型中,内淋巴囊上皮细胞的ENaC表达水平升高,表达水平与膜迷路积水严重程度正相关。本项目通过基因敲除及应用ENaC拮抗剂调控ENaC表达的动物模型,观察给予外源性ADH和醛固酮(ALD)干预前后听觉电生理、形态学及平衡功能的变化,探索ENaC在ALD和ADH造成膜迷路积水的作用及机制,为治疗梅尼埃病提供新的治疗靶点。.根据研究计划,我们成功构建豚鼠内耳膜迷路积水模型及SCNN1A基因条件敲除小鼠(Scnn1aflox/+)模型。豚鼠内耳膜迷路积水模型中,我们将ADH+ALD 组随机分为阿米洛利组和无干预组,干预后4周,阿米洛利组听觉电生理和形态学接近空白对照组,无干预组ABR阈值明显上升,形态学提示膜迷路积水。在SCNN1A基因条件敲除小鼠模型中,内耳SCNN1A敲除动物和其同窝对照,饲养一月后两组间的听觉电生理和形态学评估无明显差异,因此我们推测SCNN1A基因低表达在膜迷路积水的形成可能不是独立危险因素。.通过受试者的病史资料、听力学检测及前庭功能检查结果进行分析,前庭末梢器官受累数量与眩晕残障量表(DHI)总分以及躯体评分(DHI-P)和功能评分(DHI-F)评分成正相关,筛选出来的4个重要变量。基于此,通过遗传-神经网络模型预测DHI评分准确率达73.3%,基于k_means聚类和层次聚类,对梅尼埃病患者进行5分类,通过随访进行验证。非甾体类抗炎药物治疗3月后,梅尼埃病患者DHI评分显著改善;眩晕发作对生活的影响显著减轻,眩晕发作次数显著降低。经过查阅相关文献,发现非甾体类抗炎药药理作用可以阻断阻断梅尼埃病病人应用呋塞米后引起的急性听力学改变。因此,我们推测梅尼埃病患者的疾病严重程度与ENaC及环氧化酶的表达有重要联系。根据这些结果,我们结合本项目研究内容,对相应膜迷路积水豚鼠模型进行药物干预后进行听觉电生理和形态学检测,提取血清标本和耳蜗组织标本,相关研究正在进行中。这部分研究内容将为拓展研究方向提供重要依据。
国内基金
海外基金